Movement Alert｜ASYMCHEM Rises 5.71% in Regular Trading, CRO Sector Strength and Surging Order Backlog Drive Valuation Recovery

Market Focus09-17

On September 17, ASYMCHEM rose 5.71% in regular trading, trading at 175.9 HKD/share, with turnover of approximately 51.88 million HKD, extending a multi-day rally in the CRO sector.

On the news front, Goldman Sachs recently issued a report expressing a bullish stance on the recovery trajectory of China's CRO/CDMO industry, noting that the CXO sector collectively delivered first-half revenue growth exceeding 25% and adjusted net profit growth surpassing 66%, confirming the onset of an industry upcycle. Zhongyou Securities also recommended attention to the CXO sector, citing strong earnings visibility and attractive valuations.

At the company level, ASYMCHEM reported first-half revenue of RMB 3.607 billion, up 13.13% year-over-year, with order backlog surging 54% and new order signings increasing 55%. Emerging business revenue jumped 72.49% year-over-year. Management maintained full-year revenue growth guidance of 19%-22%, with approximately 85% of the current order backlog expected to convert into revenue in the second half through next year, supporting an acceleration in growth momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1191728220?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 09:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191728220","market":"us","top_or_hot":-1,"title":"Movement Alert｜ASYMCHEM Rises 5.71% in Regular Trading, CRO Sector Strength and Surging Order Backlog Drive Valuation Recovery","media":"Market Focus","content":"<p><p>On September 17, ASYMCHEM rose 5.71% in regular trading, trading at 175.9 HKD/share, with turnover of approximately 51.88 million HKD, extending a multi-day rally in the CRO sector.</p><p>On the news front, Goldman Sachs recently issued a report expressing a bullish stance on the recovery trajectory of China's CRO/CDMO industry, noting that the CXO sector collectively delivered first-half revenue growth exceeding 25% and adjusted net profit growth surpassing 66%, confirming the onset of an industry upcycle. Zhongyou Securities also recommended attention to the CXO sector, citing strong earnings visibility and attractive valuations.</p><p>At the company level, ASYMCHEM reported first-half revenue of RMB 3.607 billion, up 13.13% year-over-year, with order backlog surging 54% and new order signings increasing 55%. Emerging business revenue jumped 72.49% year-over-year. Management maintained full-year revenue growth guidance of 19%-22%, with approximately 85% of the current order backlog expected to convert into revenue in the second half through next year, supporting an acceleration in growth momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜ASYMCHEM Rises 5.71% in Regular Trading, CRO Sector Strength and Surging Order Backlog Drive Valuation Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜ASYMCHEM Rises 5.71% in Regular Trading, CRO Sector Strength and Surging Order Backlog Drive Valuation Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-17 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 17, ASYMCHEM rose 5.71% in regular trading, trading at 175.9 HKD/share, with turnover of approximately 51.88 million HKD, extending a multi-day rally in the CRO sector.</p><p>On the news front, Goldman Sachs recently issued a report expressing a bullish stance on the recovery trajectory of China's CRO/CDMO industry, noting that the CXO sector collectively delivered first-half revenue growth exceeding 25% and adjusted net profit growth surpassing 66%, confirming the onset of an industry upcycle. Zhongyou Securities also recommended attention to the CXO sector, citing strong earnings visibility and attractive valuations.</p><p>At the company level, ASYMCHEM reported first-half revenue of RMB 3.607 billion, up 13.13% year-over-year, with order backlog surging 54% and new order signings increasing 55%. Emerging business revenue jumped 72.49% year-over-year. Management maintained full-year revenue growth guidance of 19%-22%, with approximately 85% of the current order backlog expected to convert into revenue in the second half through next year, supporting an acceleration in growth momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"","article_id":"1191728220","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191728220","pubTimestamp":1789610021,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 17, ASYMCHEM rose 5.71% in regular trading, trading at 175.9 HKD/share, with turnover of approximately 51.88 million HKD, extending a multi-day rally in the CRO sector.On the news front,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"走势提醒|凯莱英常规交易上涨5.71%，CRO板块强劲和订单积压激增推动估值修复","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":1},"content_text":"On September 17, ASYMCHEM rose 5.71% in regular trading, trading at 175.9 HKD/share, with turnover of approximately 51.88 million HKD, extending a multi-day rally in the CRO sector.On the news front, Goldman Sachs recently issued a report expressing a bullish stance on the recovery trajectory of China's CRO/CDMO industry, noting that the CXO sector collectively delivered first-half revenue growth exceeding 25% and adjusted net profit growth surpassing 66%, confirming the onset of an industry upcycle. Zhongyou Securities also recommended attention to the CXO sector, citing strong earnings visibility and attractive valuations.At the company level, ASYMCHEM reported first-half revenue of RMB 3.607 billion, up 13.13% year-over-year, with order backlog surging 54% and new order signings increasing 55%. Emerging business revenue jumped 72.49% year-over-year. Management maintained full-year revenue growth guidance of 19%-22%, with approximately 85% of the current order backlog expected to convert into revenue in the second half through next year, supporting an acceleration in growth momentum.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191728220","isCrawlerRequest":true}